Podcast


Presenter: Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD

In episode 572, James and Mike invite Samantha Moe back to the podcast to go over the evidence around the safety and effectiveness of the monoclonal antibodies used to reduce the risk of respiratory syncytial virus (RSV) infections in infants. We go over all the numbers for hospitalizations and death so you can make evidence-informed…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Episode #33: Smoking Cessation

In this episode of In the Clinic, Mike and Jess invite back Dr. Émélie Braschi. The team discusses Xiao Yun, a 68-year old male patient who is trying to quit smoking To earn…
Listen 0.5 credits available

In the Clinic Episode #32: Pediatric Asthma

In this episode of In the Clinic, Mike and Jess invite back Dr. Jennifer Young. The team discusses Brea Salter, a 4-year old girl presenting with wheezing. To earn an additional 0.25…
Listen 0.5 credits available

BS Medicine Episode #592: Pharm for Fibro: Can antidepressants ease the pain?

In episode 592, Mike and James invite Jennifer Young back to the podcast to review the evidence around the use of antidepressants in the challenging pain condition of fibromyalgia. We…
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Mike Allan
  • Samantha Moe PharmD

Spearkers do not have any conflicts of interest to declare.